USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
CYTOGRAFT TISSUE ENGINEERING, INC.
Address:
3 HAMILTON LANDING, STE 220
NOVATO, CA 94949-
Phone:
(415) 506-0240
URL:
N/A
EIN:
133088705
DUNS:
N/A
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $736,896.00 5
SBIR Phase II $3,955,796.00 2

Award List:

N/A

Award Year / Program / Phase:
2000 / SBIR / Phase I
Award Amount:
$98,880.00
Agency:
HHS
Principal Investigator:
Todd Mcallister
Abstract:
N/a

in vivo Evaluation of a Tissue Blood Vessel

Award Year / Program / Phase:
2003 / SBIR / Phase I
Award Amount:
$0.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): Coronary heart disease is the leading cause of death in the industrialized world. Despite advances in catheter-based interventions, bypass remains the treatment with the greatest long-term efficacy. The primary limitation of this approach is the availability… More

Commercialization of a Tissue Engineered Blood Vessel

Award Year / Program / Phase:
2005 / SBIR / Phase II
Award Amount:
$2,482,151.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): The stated objective for this PA is to fund pre-clinical and clinical tests to support regulatory requirements for promising medical technologies. Accordingly, the objective of this grant is to perform process validation tests and in vivo experiments defined by… More

Cell-synthesized Thread-based Tissue Engineering

Award Year / Program / Phase:
2010 / SBIR / Phase I
Award Amount:
$215,415.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): Previously, we have reported excellent clinical results with a tissue engineered vascular graft built using a self-assembly approach termed Sheet-Based Tissue Engineering (SBTE). The principal drawback of this approac h, however, is the high manufacturing costs… More

Development of a Biological Stent Graft for Aorta Aneurysm Repair

Award Year / Program / Phase:
2010 / SBIR / Phase I
Award Amount:
$214,912.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): Abdominal aorta aneurysms (AAA) are diagnosed in more than 100,000 patients in the U.S. each year. About 70% of these patients require surgical intervention to prevent aneurysm progression. Nearly 20 years ago, Parodi r evolutionized AAA treatment and repair by… More

Cell-synthesized Thread-based Tissue Engineering

Award Year / Program / Phase:
2011 / SBIR / Phase II
Award Amount:
$1,473,645.00
Agency:
HHS
Principal Investigator:
Nicolas L'heureux – 415-506-0280
Abstract:
DESCRIPTION (provided by applicant): Cardiovascular disease is the leading cause of death in industrialized nations. While interventional techniques such as angioplasty and/or stenting can often delay the need for coronary arterial bypass surgery (CABG),long-term efficacy still favors… More

Tau Protein Aggregation Inhibitors for Tauopathies

Award Year / Program / Phase:
2013 / SBIR / Phase I
Award Amount:
$207,689.00
Agency:
HHS
Principal Investigator:
Todd N. Mcallister – 415-299-7793
Abstract:
DESCRIPTION (provided by applicant): Transcatheter aortic valve implantation (TAVI) is a minimally invasive approach to valve replacement that has had a rapid and profound clinical impact. Less than ten years after the first human use of a TAVI device, nearly 20,000 patients annually receive these… More